RESULTS OF COMBINED COMPETITIVE RADIOTHERAPY OF IIA - IIIB STAGE CERVICAL CANCER PATIENTS USING INTRACAVITARY AND INTERSTITIAL BRACHYTHERAPY

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2017-63-4-622-626

Published 01.04.2017

Isa Isaev⁺⁻
D. Aliev⁺⁻
K. Akperov⁺⁻
E. Guliev⁺⁻

Isa Isaev

National Center of Oncology

D. Aliev

National Center of Oncology

K. Akperov

National Center of Oncology

E. Guliev

National Center of Oncology

##article.numberofdownloads## 19

##article.numberofviews## 76

PDF (Русский)

Keywords

CERVICAL CANCER
INTERSTITIAL BRACHYTHERAPY
LOCAL CONTROL
CHEMORADIOTHERAPY

How to Cite

Isaev, I., Aliev, D., Akperov, K., & Guliev, E. (2017). RESULTS OF COMBINED COMPETITIVE RADIOTHERAPY OF IIA - IIIB STAGE CERVICAL CANCER PATIENTS USING INTRACAVITARY AND INTERSTITIAL BRACHYTHERAPY. Voprosy Onkologii, 63(4), 622–626. https://doi.org/10.37469/0507-3758-2017-63-4-622-626

Abstract

Treatment and investigation results of 128 IIA - IIIB stage cervical cancer patients treated by concurrent chemoradiother-apy with combined intracavitary and interstitial brachytherapy were analyzed. Interstitial brachytherapy allowed significantly increase a dose to high risk clinical target volume without elevation of the dose to surrounding organs at risk. Three-year relapse free survival did not differ significantly between intracavitary and interstitial brachytherapy groups. However analysis of local control rates depending on tumor size ant treatment modality showed higher three year relapse free survival rate for tumors > 5 cm treated by interstitial brachytherapy. Therefore interstitial brachytherapy for locally advanced cervical cancer is quite safe and effective treatment modality and could be used in daily clinical practice. But to do final conclusions we need to recruit more patients and longer follow up.

https://doi.org/10.37469/0507-3758-2017-63-4-622-626

##article.numberofdownloads## 19

##article.numberofviews## 76

PDF (Русский)

References

Алиев Д.А., Гарданлы Ф.А., Гулиев Ф.А. и др. Эпидемиологические аспекты злокачественных новообразований в Азербайджанской Республике за 2008 - 2013 гг. // Азербайджанский журнал онкологии и гематологии. - 2014. - № 2. - С. 6-12.

Алиев Д.А., Исаев И.Г., Акперов К.С., Гулиев Э.Г. Брахитерапия высокой мощностью дозы в лечении рака шейки матки // Опухоли женской репродуктивной системы. - 2011. - № 2. - С. 89-95.

Канаев С.В., Туркевич В.Г., Аввакумова В.В. Результаты сочетанной лучевой терапии рака шейки матки // Актуальные вопросы медицинской радиологии: тезисы докл. конф. - Г., 1998. - С. 271.

Козаченко В.П. Рак шейки матки // Современная онкология. - 2000. - Т. 2. - № 2. - С. 40-44.

Шакирова Э.Ж., Гуллагалиева А.Г., Хасанов Р.Ш., Сухорукова Л.К. Гестнораспространенный рак шейки матки: проблемы диагностики и лечения // Казанский медицинский журнал. - 2007. - Т. 88. - № 6. - С. 627-630.

Fokdal L., Sturdza A., Mazeron R. et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retro-EMBRACE study // Radiotherapy and Oncology. - 2016. - Vol.120. - P. 434-440.

GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012, http://globocan.iarc.fr.

Han K., Croke J., Foltz W. et al. Prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer // Radiotherapy and Oncology. - 2016. - Vol.120. - P. 519-525.

Hanna T., Delaney G., Barton M. The population benefit of radiotherapy for gynaecological cancer: Local control and survival estimates // Radiotherapy and Oncology. - 2016. - Vol.120. - P. 370-377.

Jastaniyah N., Yoshida K., Tanderup K. et al. A volumetric analysis of GTVD and CTVHR as defined by the GEC ES-TRO recommendations in FIGO stage IIB and IIIB cervical cancer patients treated with IGABT in a prospective mul-ticentric trial (EMBRACE) // Radiotherapy and Oncology. - 2016. - Vol. 120. - P. 404-411.

Minig L., Patrono M., Romero N. et al. Different strategies of treatment for uterine cervical carcinoma stage IB2-IIIB // World J. Clin. Oncol. - 2014. - Vol. 5 (2). - P. 86-92.

Mohamed S., Kallehauge J., Fokdal L. et al. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial Brachytherapy vs. intracavitary Brachytherapy plus external beam radiotherapy // Brachytherapy. - 2015. - Vol. 14(1). - P. 23-28.

Ribeiro I., Janssen H., Brabandere M. et al. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients // Radiotherapy and Oncology. - 2016. - Vol.120. - P. 447-454.

Soliman A., Elzibak A., Easton H. et al. Quantitative MRI assessment of a novel direction modulated brachytherapy tandem applicator for cervical cancer at 1.5 T // Radiotherapy and Oncology. - 2016. - Vol. 120. - P. 500-506.

Tanderup K., Fokdal L., Sturdza A. et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachy-therapy of locally advanced cervical cancer // Radiotherapy and Oncology. - 2016. - Vol. 120. - P. 441-446.

Viswanathan A., Beriwal S., Santos J. et al. The American Brachytherapy Society Treatment Recommendations for Locally Advanced Carcinoma of the Cervix Part II: High Dose-Rate Brachytherapy // Brachytherapy. - 2012. -Vol.14 (1). - P. 47-52.

Yahya S., Bhatt L., King M. et al. Survival and toxicity following chemoradiation for carcinoma of the cervix - impact of multiple-phase treatment and shielding // Anticancer Res. - 2015. - Vol. 35 (10). - P. 5567-5574.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.